Since its establishment in 1997, Cambridge Biomedical has supported sponsors and CROs developing customized assays for small and large molecules, biomarkers, diagnostics, and medical devices. Our team has expertise and extensive experience in technology transfer, assay development, optimization, and validation. We are positioned to work with you at preclinical, clinical, and post-market stages of drug or device development.
We employ senior scientists at the PhD, MD, and MD/PhD level. Our accomplished staff are experts in complex and custom assay development and validation, and are able to perform across a broad range of therapeutic areas.